Search by Drug Name or NDC

NDC 53002-1712-03 Mirtazapine 45 mg/1 Details

Mirtazapine 45 mg/1

Mirtazapine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is MIRTAZAPINE.

MedlinePlus Drug Summary

Mirtazapine is used to treat depression. Mirtazapine is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain to maintain mental balance.

Related Packages: 53002-1712-03
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mirtazapine

Product Information

NDC	53002-1712
Product ID	53002-1712_a0a3ba9e-ebb6-4b3d-99da-a420eff6bced
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Mirtazapine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Mirtazapine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	45
Active Ingredient Units	mg/1
Substance Name	MIRTAZAPINE
Labeler Name	RPK Pharmaceuticals, Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077666
Listing Certified Through	2024-12-31

Package

NDC 53002-1712-03 (53002171203)

Pricing Information	N/A
NDC Package Code	53002-1712-3
Billing NDC	53002171203
Package	30 TABLET, FILM COATED in 1 BOTTLE (53002-1712-3)
Marketing Start Date	2018-10-01
NDC Exclude Flag	N